“…However, the PAMPA assay has found so far greater acceptance for gastrointestinal tract passive transport prediction, since a broader spectrum of nanomedicines has already been tested, such as polymeric micelles [128], [129,130], liposomes [131,132], solid lipid nanoparticles [133] and solid self-nanoemulsifying drug delivery systems [134,135]. Overall, results pointed out that inclusion in nanocarriers may significantly alter the passive diffusion pattern of the free drug.…”